| Dr Justine Ashokar, PHD | |
|
803 Soo San Dr, Rapid City, SD 57702-3142 | |
| (605) 718-8446 | |
| (605) 721-9858 |
| Full Name | Dr Justine Ashokar |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 9 Years |
| Location | 803 Soo San Dr, Rapid City, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790222008 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 550 (South Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Black Hills Works Inc | 0244297349 | 2 |
News Archive
Engineers at the University of California San Diego have developed a desktop diagnosis tool that detects the presence of harmful bacteria in a blood sample in a matter of hours instead of days.
The use of stem cell therapy to prevent heart attacks is explored in a Comment published in this week's edition of The Lancet.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
Genevac announced its popular miVac SpeedTrap cold trap can be used for freeze drying or configured as a combined concentration / freeze drying workstation.
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.
› Verified 7 days ago
| Entity Name | Black Hills Works Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992850952 PECOS PAC ID: 0244297349 Enrollment ID: O20041209001083 |
News Archive
Engineers at the University of California San Diego have developed a desktop diagnosis tool that detects the presence of harmful bacteria in a blood sample in a matter of hours instead of days.
The use of stem cell therapy to prevent heart attacks is explored in a Comment published in this week's edition of The Lancet.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
Genevac announced its popular miVac SpeedTrap cold trap can be used for freeze drying or configured as a combined concentration / freeze drying workstation.
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justine Ashokar, PHD 2605 Tomahawk Dr, Rapid City, SD 57702-5254 Ph: (605) 718-8446 | Dr Justine Ashokar, PHD 803 Soo San Dr, Rapid City, SD 57702-3142 Ph: (605) 718-8446 |
News Archive
Engineers at the University of California San Diego have developed a desktop diagnosis tool that detects the presence of harmful bacteria in a blood sample in a matter of hours instead of days.
The use of stem cell therapy to prevent heart attacks is explored in a Comment published in this week's edition of The Lancet.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
Genevac announced its popular miVac SpeedTrap cold trap can be used for freeze drying or configured as a combined concentration / freeze drying workstation.
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.
› Verified 7 days ago
Sandra Jensen, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4851 Cliff Dr, Rapid City, SD 57702 Phone: 850-339-7660 | |
Mrs. Trisha Terrean Miller, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Fulton St, Suite 201, Rapid City, SD 57702 Phone: 605-348-6565 Fax: 605-341-7409 | |
Dr. Robin Nicole Wisniewski, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 636 Saint Anne St, Rapid City, SD 57701 Phone: 605-721-8822 | |
Thomas Brey, ED.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 21 Saint Joseph St, Rapid City, SD 57701 Phone: 605-394-4036 | |
Kaylee Trottier, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7110 Jordan Dr, Rapid City, SD 57702 Phone: 605-791-7414 | |
Julie Remmereid, ED.S Psychologist Medicare: Not Enrolled in Medicare Practice Location: 10 Van Buren St, Rapid City, SD 57701 Phone: 605-394-1841 Fax: 605-394-1739 | |
Madisen Schreiber, ED.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 21 Saint Joseph St, Rapid City, SD 57701 Phone: 605-394-4036 |